MyFinsight
Home
Blog
About
Contact
Proceeds from the sale and
maturities of investments
$30,050K
Net cash provided by
investing activities
$28,734K
Canceled cashflow
$1,316K
Net increase
(decrease) in cash and cash...
-$7,754K
Canceled cashflow
$28,734K
Exercise of stock options
$7,895K
Net loss
$56,060K
Remeasurement of omidria
contract royalty asset
$32,552K
Omidria contract
royalty asset
-$7,343K
Amortization of discount and
issuance costs-Loans...
$4,727K
Stock-based compensation
expense
$1,889K
Amortization of discount and
issuance...
$1,460K
Depreciation and
amortization
$239K
Prepaid expenses and
other
-$87K
Purchases of investments
$1,316K
Net cash used in
financing activities
-$21,982K
Canceled cashflow
$7,895K
Net cash used in
operating activities
-$14,506K
Canceled cashflow
$104,357K
Repayment of 2026 notes
$17,077K
Principal payments on
omidria royalty...
$4,670K
Repurchases of common stock
$4,152K
Net share
settlement of equity awards
$4,108K
Remeasurement on fair value of
financial instruments
$73,146K
something is missing
-$38,898K
Non-cash interest on
omidria contract...
$3,132K
Non-cash interest
remeasurement on omidria...
-$1,410K
Receivables
$1,115K
Accounts payable and
accrued expense
-$979K
Inventory
$183K
Back
Back
Cash Flow
OMEROS CORP (OMER)
OMEROS CORP (OMER)
source: myfinsight.com